1.0Press Arabiahttps://pressarabia.qaadminhttps://pressarabia.qa/author/admin01/Advanced Aesthetic Technologies, Inc. Announces the Treatment of the First Patient in a Pivotal Clinical Trial in China with their Algeness® VL (2.5% Agarose Gel) Filler for the Correction of Moderate to Severe Nasolabial Folds - Press Arabiarich600338<blockquote class="wp-embedded-content" data-secret="6GPiCMGQCO"><a href="https://pressarabia.qa/advanced-aesthetic-technologies-inc-announces-the-treatment-of-the-first-patient-in-a-pivotal-clinical-trial-in-china-with-their-algeness-vl-2-5-agarose-gel-filler-for-the-correction-of/">Advanced Aesthetic Technologies, Inc. Announces the Treatment of the First Patient in a Pivotal Clinical Trial in China with their Algeness® VL (2.5% Agarose Gel) Filler for the Correction of Moderate to Severe Nasolabial Folds</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://pressarabia.qa/advanced-aesthetic-technologies-inc-announces-the-treatment-of-the-first-patient-in-a-pivotal-clinical-trial-in-china-with-their-algeness-vl-2-5-agarose-gel-filler-for-the-correction-of/embed/#?secret=6GPiCMGQCO" width="600" height="338" title="“Advanced Aesthetic Technologies, Inc. Announces the Treatment of the First Patient in a Pivotal Clinical Trial in China with their Algeness® VL (2.5% Agarose Gel) Filler for the Correction of Moderate to Severe Nasolabial Folds” — Press Arabia" data-secret="6GPiCMGQCO" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
This new clinical trial is being conducted through their partnership with Lanzhou Biotechnique Development Co., LTD (LanDev) and their parent company China National Biotec Group Co., LTD (CNBG) and will be used to seek marketing approval in China BROOKLINE, Mass., June 24, 2021 /PRNewswire/ — Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel […]https://ci3.googleusercontent.com/proxy/DGBUEDBTHPMDh3T_GtCQOFTiZ0QF_2u3V9YR2tXUTao40HBsGtUNAFMHX1903JREGr_VzUZN8gSiS21LsfncqV-gdfW7OWZA=s0-d-e1-ft#https://mma.prnewswire.com/media/1550223/AAT_Logo.jpg